Cancer vaccines have gained much interest among scientists but face a number of hurdles. A new mRNA vaccine for glioma offers a step forward in training the immune system to fight cancer.
Rigor académico, oficio periodístico
Artículos sobre mRNA
Mostrando 1 - 20 de 51 artículos
The COVID-19 pandemic demonstrated the promise of using mRNA as medicine. But before mRNA drugs can go beyond vaccines, researchers need to identify the right diseases to treat.
From COVID-19 vaccines to cancer treatments and beyond, the flexibility of mRNA-based therapies gives them the potential to prevent and treat many types of diseases.
Considered a pipe dream not too long ago, research on RNA therapeutics is progressing rapidly. Now a new manufacturing protocol will help researchers to advance the technology.
This is an era of exciting advances in medical science. But Africa is in danger of being at the back of the queue once again. What should we be doing to make sure this doesn’t happen?
The goal of mRNA technology is to harness the power of the cell to potentially prevent infections and treat diseases.
The winners of the 2023 Nobel Prize in physiology or medicine made a discovery that helped create the COVID-19 vaccines. They couldn’t have anticipated the tremendous impact of their findings.
The prestigious prize was awarded to Dr Katalin Karikó and Dr Drew Weissman from the University of Pennsylvania.
This study further highlights the potential of mRNA vaccines in cancer treatment.
With the emergency phase of the COVID-19 pandemic in the rearview mirror, at least for now, we look back on a handful of stories that provided sharp insights at key moments in the pandemic.
While mRNA vaccines are designed to last longer in the body than mRNA molecules typically would, they are also tested to ensure they are eliminated from livestock long before milking or slaughter.
Cancer vaccines are an emerging personalised treatment for cancer. Using the same mRNA technology as COVID vaccines, they stimulate the immune system to destroy cancer cells.
Here’s why it’s taken so long to develop a vaccine for respiratory syncytial virus and what we can expect next.
Annual flu vaccines are in a constant race against a rapidly mutating virus that may one day cause the next pandemic. A one-time vaccine protecting against all variants could give humanity a leg up.
The CDC’s endorsement of the reformulated COVID-19 booster shots represents a major step in the effort to get more Americans boosted.
Research suggests that too-frequent immunizations may lead to a phenomenon called “immune exhaustion.”
A robust body of research finds that getting vaccinated against COVID-19 during pregnancy is safe and effective – and the best way to protect both mother and child from the risks of COVID-19.
The COVID-19 pandemic has brought immunology terms that are typically relegated to textbooks into our everyday vernacular. These stories helped us make sense of the ever-evolving science.
Some of the omicron variant’s unique properties – such as its ability to spread rapidly while causing milder COVID-19 infections – could usher in a new phase of the pandemic.
DNA and mRNA vaccines produce a different kind of immune response than traditional vaccines, allowing researchers to tackle some previously unsolvable problems in medicine.
Principales colaboradores
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Professor of Microbiology, School of Medicine, University of Washington
-
Associate Professor and ARC Future Fellow, The University of Western Australia
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Professor of Medicine, University of Virginia
-
Postdoctoral Research Fellow, RNA Biology and Biochemistry, Brighton and Sussex Medical School
-
Pediatric Infectious Diseases Fellow, University of Pittsburgh
-
Clinical Associate Professor of Pharmacy Practice, Binghamton University, State University of New York
-
Early Career Research Leader, Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University
-
Professor and Department Chair of Infectious Diseases and Microbiology, University of Pittsburgh
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Professor of virology and theme leader for viral infectious diseases, The Peter Doherty Institute for Infection and Immunity
-
Senior Lecturer; MD, Victoria University
-
Professor and Director of Quantitative Biosciences Institute & Senior Investigator at the Gladstone Institutes, University of California, San Francisco
